ONDQA Perspective on Post Approval Changes
ONDQA Perspective on Post Approval Changes. Eric P. Duffy, PhD Director, Division of Post-Market Evaluation, ONDQA, CDER, FDA Public Meeting: Supplements and Other Changes to an Approved Application Feb. 7, 2007,Gaithersburg MD. Overview. What is quality by design (QbD)?
436 views • 12 slides